December 23, 2025 • As soon as Alternate Realities publishes, Zach Mack calls his dad to hear his reactions to the series. The conversation takes an unexpected turn, launching them into another ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

The first event in the new series Deep Dive, which invites audiences to listen — really listen — to artists who have shaped our musical imagination, focuses on Bad Bunny. The Puerto Rican reguetonero, ...

Sharpen your pickaxes and comb your beards, because the Deep Rock Galactic Season 6 release date is closer than initially thought. It will continue the story of Season 5 Digging Deeper, which launched ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Hon Hai Tech Day (HHTD) opened on November 21, 2025, with founder Terry Guo present, as chairman Young Liu again rejected the long-held view that Foxconn is only a contract assembler. He underscored ...

Just off of Old Taughannock Boulevard, facing the Cayuga Inlet, the dimly lit windows of Deep Dive look in on how music dances and swerves its way through clusters of people enjoying drinks by the bar ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Hello, everybody, and welcome to Recursion's Third Quarter 2025 (L)earnings Call. My name is Chris Gibson. I'm the Co-Founder and current CEO of Recursion, and I'm so delighted to have you all joining ...

Legal teams now can rapidly uncover and verify key evidence across tens of millions of documents using simple, conversational queries Everlaw plans for Deep Dive to be generally available to customers ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...